Last reviewed · How we verify

NCT05574257

Comparison of the Effect of Remimazolam and Propofol on Perioperative Hypothermia Under Spinal Anesthesia

Completed NA Last updated 10 October 2022
What this trial tests

NA trial testing Propofol in Lower Extremity Problem in 82 participants. Completed in 2 September 2022.

Timeline
1 February 2022
Primary endpoint
30 May 2022
2 September 2022

Quick facts

Lead sponsorWonkwang University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment82
Start date1 February 2022
Primary completion30 May 2022
Estimated completion2 September 2022
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Wonkwang University Hospital

Who can join

Adults 19 to 65, any sex, with Lower Extremity Problem or Gynecologic Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

After dividing the patients into two groups, sedation is performed with propofol and remimazolam, respectively, after spinal anesthesia. Compare the patient's body temperature change after surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Propofol

Trials testing the same drug.

Other recruiting trials for Lower Extremity Problem

Currently open trials in the same condition.

Other Wonkwang University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05574257.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing